Abstract
In recent months, the world has suffered from the appearance of a new strain of coronavirus, causing the COVID-19 pandemic. There are great scientific efforts to find new treatments and vaccines, at the same time that governments, companies, and individuals have taken a series of actions in response to this pandemic. These efforts seek to decrease the speed of propagation, although with significant social and economic costs. Countries have taken different actions, also with different results. In this article we use non-parametric techniques (HT and MST) with the aim of identifying groups of countries with a similar spread of the coronavirus. The variable of interest is the number of daily infections per country. Results show that there are groups of countries with differentiated contagion dynamics, both in the number of contagions plus at the time of the greatest transmission of the disease. It is concluded that the actions taken by the countries, the speed at which they were taken and the number of tests carried out may explain part of the differences in the dynamics of contagion.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All relevant ethical guidelines have been followed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
* The authors would like to acknowledge the many valuable suggestions made by the participants at the GIDE Seminar
Data Availability
The data used in this manuscript are available at https://ourworldindata.org/coronavirus
